--

Dr Miranda Payne is a Consultant in Medical Oncology, specialising exclusively in
the treatment of skin cancers, with particular expertise in the systemic
treatment of melanoma including non-cutaneous melanoma. 

Miranda took a first in Physiology from the University
of Oxford before completing her clinical training in 1999. In 2006 Miranda was
awarded a Cancer Research UK Clinical Fellowship, spending four years carrying
our laboratory research in DNA repair at the Weatherall Institute of Molecular
Medicine, leading to a DPhil in Medical Oncology. Specialist training was
completed in Oxford, where she is now the Clinical Lead for Oncology at the
Oxford University Hospitals NHS Foundation Trust.

In her NHS practise, recruitment to international, academic,
industry-sponsored and observational clinical trials is a routine aspect of Miranda's
clinical practice, reflected in her publication record. She has a special
interest in the consequences of immunotherapy and in the management of mucosal
melanoma. 

Miranda is the Thames Valley and South Midlands Skin Cancer Research Lead, was an elected member of the National Cancer Research Institute Skin Group, is a co-author of the recently published UK guidelines for the management of both Ano-uro-genital Mucosal Melanoma and Head & Neck Mucosal Melanoma, works with Melanoma Focus (the UK national charity dedicated to research, treatment, education and information for patients, their families and their clinical teams) and has been an editor of
the Oxford Handbook of Oncology for almost twenty years.